Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is conventionally characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), accounting for approximately 15–20% of all breast cancers. Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiying, Zhang, Rui, Li, Donghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520847/
https://www.ncbi.nlm.nih.gov/pubmed/37767463
http://dx.doi.org/10.2147/BTT.S426392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520847/
https://www.ncbi.nlm.nih.gov/pubmed/37767463
http://dx.doi.org/10.2147/BTT.S426392

Ejemplares similares